Evidence map›Paper›PMID 29954364›Full record

ArticleBMC pregnancy and childbirth2018

The impact of FSH receptor polymorphism on time-to-pregnancy: a cross-sectional single-centre study.

Birute Zilaitiene, Marius Dirzauskas, Rasa Verkauskiene, Rytas Ostrauskas, Joerg Gromoll, Eberhard Nieschlag

Open access · goldAbstract read
In one paragraph

Article in BMC pregnancy and childbirth, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Metformin-Driven Activation of Polymorphic Follicle-Stimulating Hormone Receptors for Polycystic Ovary Syndrome Treatment: A Computational Study.Medical science monitor : international medical journal of experimental and clinical research · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Birute ZilaitieneInstitute of Endocrinology, Lithuanian University of Health Sciences, 50009, Kaunas, Lithuania. birute.zilaitiene@lsmuni.lt.
Marius DirzauskasInstitute of Endocrinology, Lithuanian University of Health Sciences, 50009, Kaunas, Lithuania.
Rasa VerkauskieneInstitute of Endocrinology, Lithuanian University of Health Sciences, 50009, Kaunas, Lithuania.
Rytas OstrauskasInstitute of Endocrinology, Lithuanian University of Health Sciences, 50009, Kaunas, Lithuania.
Joerg GromollCenter of Reproductive Medicine and Andrology, University of Münster, 48149Münster, Münster, Germany.
Eberhard NieschlagCenter of Reproductive Medicine and Andrology, University of Münster, 48149Münster, Münster, Germany.
Lithuanian University of Health Sciences · LTUniversity of Münster · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSingle nucleotide polymorphism of the follicle-stimulating hormone (FSH) receptor (FSHR) is an important marker of ovarian function. However, its role in female fecundity remains debatable. The aim of the study to assess the relationship of FSHR polymorphism of Serine/Serine, Asparagine/Asparagine and Asparagine/Serine variants directly against the time-to-pregnancy (TTP) in women.

methodsData were collected from 291 consecutive selected post-partum Caucasians using this criterion: ethnicity, age between 21 and 34-year-old new mothers and, 0-3 days after delivery of newborns in the Klaipeda University Hospital, Lithuania. Questionnaires on factors associated with conception were given to patients, and blood samples were collected for genomic DNA extractions as well as for analysis of follicle-stimulating hormone receptor gene polymorphism. Odds ratios (OR) and 95% confidence intervals (CI) for time-to-pregnancy were estimated by multivariate logistic regression. Women with unplanned pregnancies and those who received assisted reproductive technologies were not included in the study.

resultsAfter adjustment for other possible factors, increased risk for time-to-pregnancy of 12 or more months was associated with: Serine/Serine polymorphism variant (OR = 1.38, 95% CI 1.56-2.71, p = 0.007), age of 30 or more years (OR = 1.95, 95% CI 1.25-2.71, p = 0.015), gynaecological diseases in the past (OR = 2.21, 95% CI 1.12-5.74, p = 0.027), prior contraception use (OR = 1.87, 95% CI 1.14-3.64, p = 0.016), and fertility problems in the past (OR = 1.57, 95% CI 1.16-4.76, p = 0.019).

conclusionThe results suggest a possible relationship of FSH receptor gene Serine/Serine variant for the lower possibility of conception during the first 12 months of planned conception.

Indexed as

AdultCross-Sectional StudiesFemaleGenotypeHumansLithuaniaPolymorphism, Single NucleotidePregnancyPrognosisReceptors, FSHRisk AssessmentSensitivity and SpecificityTime-to-PregnancyYoung AdultReceptors, FSHFSH receptor haplotypesFSH receptor polymorphismTime to pregnancy

Identifiers

PMID29954364
PMCPMC6025715
OpenAlexW2811085457

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.